Product Overview: Biopeptide Ipamorelin LIFETECH LABS
Ipamorelin is a selective growth hormone secretagogue peptide originally developed by Novo Nordisk for investigating growth hormone axis modulation. As a synthetic pentapeptide with molecular weight 711.85 g/mol and CAS number 170851-70-4, this compound functions as a selective ghrelin receptor agonist in preclinical research models. Unlike broader-spectrum GH secretagogues, ipamorelin demonstrates remarkable selectivity, stimulating growth hormone release without significantly affecting cortisol or prolactin pathways in animal studies. Research institutions studying metabolic regulation and endocrine pathways commonly investigate this compound alongside other research chemicals available through Stroid UK Shop for comprehensive laboratory investigations.
Research Applications in Laboratory Studies
Laboratory research with ipamorelin has progressed through Phase II clinical trials for post-surgical ileus, demonstrating its potential therapeutic relevance in controlled research environments. Preclinical studies examine its selective activation of ghrelin receptors, which triggers pulsatile growth hormone secretion without the broader hormonal disruption associated with less selective compounds. Researchers investigating ipamorelin peptide products often examine its unique selectivity profile compared to traditional growth hormone releasing peptides. The compound’s mechanism involves specific binding to growth hormone secretagogue receptors, making it valuable for researchers studying targeted endocrine modulation. Many research protocols combine ipamorelin studies with other peptide compounds to examine synergistic effects in metabolic research models. Additionally, comparative studies often investigate ipamorelin alongside SARM compounds to evaluate different pathways affecting growth factor signalling.
Technical Specifications
| Molecular Formula | C38H49N9O5 |
|---|---|
| Molecular Weight | 711.85 g/mol |
| CAS Number | 170851-70-4 |
| Purity Grade | Research Grade |
| Storage Conditions | -20°C (lyophilised powder) |
| Solubility | Water soluble when reconstituted |
| Appearance | White lyophilised powder |
Regulatory Compliance
This ipamorelin product is manufactured exclusively for in-vitro laboratory research applications and is not approved for human consumption, therapeutic use, or clinical applications. Researchers must ensure appropriate laboratory protocols, proper storage conditions, and compliance with institutional research guidelines when conducting studies with this compound. All research activities must be conducted in appropriate laboratory settings with qualified personnel and proper safety measures.
